In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and Enterococci
- 31 March 1995
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 21 (3) , 169-173
- https://doi.org/10.1016/0732-8893(95)00068-l
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogensAntimicrobial Agents and Chemotherapy, 1995
- In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organismsAntimicrobial Agents and Chemotherapy, 1993
- RP 59500: a proposed mechanism for its bactericidal activityJournal of Antimicrobial Chemotherapy, 1992
- The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combinationJournal of Antimicrobial Chemotherapy, 1992
- In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studiesJournal of Antimicrobial Chemotherapy, 1992
- Comparative in-vitro activity of RP 59500 against clinical bacterial isolatesJournal of Antimicrobial Chemotherapy, 1992
- In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against Gram-positive bacteriaJournal of Antimicrobial Chemotherapy, 1992
- Synergistic Bactericidal Activity of Rat Serum with Vancomycin against EnterococciThe Journal of Infectious Diseases, 1991
- In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciAntimicrobial Agents and Chemotherapy, 1991
- Antimicrobial Therapy of Experimental Enterococcal EndocarditisAntimicrobial Agents and Chemotherapy, 1975